GEN1046 Safety Trial in Patients With Malignant Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumors|Non-small Cell Lung Cancer|Urothelial Carcinoma|Endometrial Carcinoma|Triple Negative Breast Cancer|Squamous Cell Carcinoma of the Head and Neck|Cervical Cancer
Interventions: BIOLOGICAL: Acasunlimab|BIOLOGICAL: Acasunlimab in combination with docetaxel (in a single expansion cohort)|BIOLOGICAL: Acasunlimab in combination with pembrolizumab (in a separate expansion cohort)|BIOLOGICAL: Acasunlimab in combination with pembrolizumab and standard chemotherapy (in separate expansion cohorts)
Sponsor: Genmab
Collaborators: BioNTech SE